The cell-based approach in neurosurgery: ongoing trends and future perspectives
Prognostic factors for glioblastoma patients – a clinical population‐based study - Fekete - 2016 - Acta Neurologica Scandinavica - Wiley Online Library
DNA methylation profile in cultured cells and their correlation to the... | Download Scientific Diagram
OS3 MODELS
Innovative therapies for malignant brain tumors: the road to a tailored cure | Acta Bio Medica Atenei Parmensis
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
ELSOXFDATP045\Commun\MARKETING ELSEVIER-MASSON\POLE MARKETING B TO C\2.REVUES\2.Emailings Revues\E-mailing 2019\z_Elements_Cam
PDF) Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
Cytovac | ALECSAT
PDF) P06.08 BRAINTuNE: Brain Tumor Neoepitope Evaluation for personalized glioma immunotherapy
Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges
Angiogenesis in glioma
Adoptive immunotherapies in neuro-oncology: classification, recent advances, and translational challenges
Studies for Better Treatment of Patients with Glioma
Hallmarks of glioblastoma: a systematic review
ALECSAT - Wikipedia
Cancers | Free Full-Text | Therapeutic Strategies for Overcoming Immunotherapy Resistance Mediated by Immunosuppressive Factors of the Glioblastoma Microenvironment | HTML
Overview of current immunotherapeutic strategies for glioma | Immunotherapy
Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells - ScienceDirect
Overview of current immunotherapeutic strategies for glioma | Immunotherapy
